304 related articles for article (PubMed ID: 31171906)
21. Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury.
Zhou L; Xu DY; Sha WG; Shen L; Lu GY
Biochem Biophys Res Commun; 2018 Sep; 503(2):849-855. PubMed ID: 29928873
[TBL] [Abstract][Full Text] [Related]
22. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus.
Zhang Y; Wu H; Wang F; Ye M; Zhu H; Bu S
Int J Gynaecol Obstet; 2018 Feb; 140(2):164-169. PubMed ID: 29110299
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
Wang SH; Zhang WJ; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Oncotarget; 2016 Jun; 7(25):37857-37867. PubMed ID: 27191262
[TBL] [Abstract][Full Text] [Related]
25. MALAT1 Promotes Cell Apoptosis and Suppresses Cell Proliferation in Testicular Ischemia-Reperfusion Injury by Sponging MiR-214 to Modulate TRPV4 Expression.
Li W; Ning JZ; Cheng F; Yu WM; Rao T; Ruan Y; Yuan R; Zhang XB; Du Y; Xiao CC
Cell Physiol Biochem; 2018; 46(2):802-814. PubMed ID: 29870987
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MALAT1 is Neuroprotective in a Rat Model of Spinal Cord Ischemia-Reperfusion Injury Through miR-204 Regulation.
Qiao Y; Peng C; Li J; Wu D; Wang X
Curr Neurovasc Res; 2018; 15(3):211-219. PubMed ID: 29998804
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
Li Z; Xu C; Ding B; Gao M; Wei X; Ji N
J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.
Li X; Zeng L; Cao C; Lu C; Lian W; Han J; Zhang X; Zhang J; Tang T; Li M
Exp Cell Res; 2017 Jan; 350(2):327-335. PubMed ID: 27964927
[TBL] [Abstract][Full Text] [Related]
31. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
[TBL] [Abstract][Full Text] [Related]
32. Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke.
Guo D; Ma J; Yan L; Li T; Li Z; Han X; Shui S
Cell Physiol Biochem; 2017; 43(1):182-194. PubMed ID: 28854438
[TBL] [Abstract][Full Text] [Related]
33. Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells.
Xiang J; Guo S; Jiang S; Xu Y; Li J; Li L; Xiang J
J Korean Med Sci; 2016 May; 31(5):688-94. PubMed ID: 27134488
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22.
Song Y; Yang L; Guo R; Lu N; Shi Y; Wang X
Biochem Biophys Res Commun; 2019 Feb; 509(2):359-366. PubMed ID: 30591217
[TBL] [Abstract][Full Text] [Related]
35. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
36. The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury.
Wang L; Li S; Stone SS; Liu N; Gong K; Ren C; Sun K; Zhang C; Shao G
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053294
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
38. MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complications.
Puthanveetil P; Gutschner T; Lorenzen J
Hypertens Res; 2020 May; 43(5):372-379. PubMed ID: 31853043
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury.
Kölling M; Genschel C; Kaucsar T; Hübner A; Rong S; Schmitt R; Sörensen-Zender I; Haddad G; Kistler A; Seeger H; Kielstein JT; Fliser D; Haller H; Wüthrich R; Zörnig M; Thum T; Lorenzen J
Sci Rep; 2018 Feb; 8(1):3438. PubMed ID: 29467431
[TBL] [Abstract][Full Text] [Related]
40. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
